FindTrial
Sign In

Comparison of two drugs Lignocaine and Dexmedetomidine for fiberoptic guided awake nasal intubation in traumatic maxillofacial surgeries for the ease of intubation

Effect of Lignocaine nebulisation with and without Dexmedetomidine for flexible fiberoptic guided awake nasal intubation in traumatic maxillofacial surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071334
Enrollment
110
Registered
2024-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Lignocaine nebulisation: All the patient undergoing traumatic maxillofacial surgeries will be nebulized with lignocaine which is a local anaesthetic for awake nasal intubation Control I

Sponsors

Peoples Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1 and 2 All patients scheduled for elective maxillofacial surgeries

Exclusion criteria

Exclusion criteria: Patient refusal ASA grade 3 and 4 Pregnancy and lactating mother Hemodynamic instability Allergy to study drugs Patient with nasal polyps and mass

Design outcomes

Primary

MeasureTime frame
ease of intubationTimepoint: 40 minutes—

Secondary

MeasureTime frame
Onset of action hemodynamic parameters patient comfort cough responseTimepoint: 40 minutes—

Countries

India

Contacts

Public ContactDr Ayush Sohani

Peoples College of Medical Sciences and Research Centre

drmahimabatra@gmail.com975207418

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026